πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6342221

Antibody conjugate compositions for selectively inhibiting VEGF

The Board of Regents of the University of Texas System Β· Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6342216

Therapy of cancer by insect cells containing recombinant baculovirus encoding genes

The Board of Regents of the University of Texas System Β· Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6337206

Nucleic acid encoding mouse galanin receptor (GALR2)

The Board of Regents of the University of Texas System Β· Granted Tue Jan 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6333313

Clinical use of oxytocin alone or in combination to treat bone disorders

The Board of Regents of the University of Texas System Β· Granted Tue Dec 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6331284

P202 is a tumor suppressor

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6326356

Suppression of neu overexpression using a mini-E1A gene

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6323226

Treatment of heart disease with cox-2 inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6313155

Composition and method for treating macular disorders

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6312694

Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6309854

Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6309644

Parasitic nematode transglutaminase proteins and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6309352

Real time optoacoustic monitoring of changes in tissue properties

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6300308

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System Β· Granted Tue Oct 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6300101

Methods and compositions including a 13kD B. burgdorferi protein

The Board of Regents of the University of Texas System Β· Granted Tue Oct 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6296849

Methods and compositions including a 13kDa B. burgdorferi protein

The Board of Regents of the University of Texas System Β· Granted Tue Oct 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6294650

Inhibition of mammalian telomerase by peptide nucleic acids

The Board of Regents of the University of Texas System Β· Granted Tue Sep 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6287607

Potassium calcium citrate compositions and methods therefor

The Board of Regents of the University of Texas System Β· Granted Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6280958

Rh blood group antigen compositions and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Aug 28 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6277375

Immunoglobulin-like domains with increased half-lives

The Board of Regents of the University of Texas System Β· Granted Tue Aug 21 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6271207

Enhanced expression of transgenes

The Board of Regents of the University of Texas System Β· Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6271201

Methods for the selective regulation of placental prostanoids and inhibition of labor usin

The Board of Regents of the University of Texas System Β· Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6265214

Methods and compositions for inducing monocyte cytotoxicity

The Board of Regents of the University of Texas System Β· Granted Tue Jul 24 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6262257

Calixpyrroles, calixpyridinopyrroles and calixpyridines

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6262242

Tumor suppressor designated TS10Q23.3

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired